Investor’s information

Promethera^® Biosciences has completed in October 2009 a first round of financing (A round) of 5.3 million euros. This round is lead by Vesalius Biocapital and regroupes several investors, business angels and the Université Catholique de Louvain through Sopartec SA and the Vives Fund.

Funding will be dedicated to promote the first three years of Promethera^® Biosciences' activities and to bring Promethera^® HepaStem to clinical phases as well as to bring Promethera^® HepaScreen up to the market.

The current investor's are:

Details on investors:

Vesalius Biocapital S.A. SICAR is a venture capital fund focusing on the creation and growth of European non-quoted life science companies. The Fund invests in those areas that have highest profit potential: new therapeutics, cutting-edge medical devices, innovative drug delivery technologies as well as (non-) clinical diagnostics and screening tests with a high utility level.

LRM is a profit driven investor. It offers entrepreneurs a unique combination of venture capital, project financing and real estate. LRM invests in the Life Sciences sector, focussing on promising players. LRM provides companies with the necessary instruments to develop faster and create added value for all stakeholders.

Sopartec SA/Vives Fund

Sopartec is the Technology Transfer Office and fully owned subsidiary of the Université catholique de Louvain (UCL). In close cooperation with the UCL Research Administration (ADRE - Administration de la Recherche), Sopartec is in charge of the management and commercialization of the UCL Intellectual Property for the benefit of society, the regional economy, the inventors and the University.

Sopartec is also managing the Vives fund, a  €15 M seed investment fund dedicated to technology companies exploiting the R&D performed in UCL.

The SRIW (Société Régionale d'Investissement de Wallonie) Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st Century.

NivelInvest/Start-up SA

NivelInvest was created in march 1987 as a joint venture between public and private sectors to bring financial and human means dedicated to promotion, development management, strategic guidance, diversification and relocation of business in the Brabant Wallon Area in order to better valorize regional ressources and create stable and durable environment.

Capital & Croissance groupe investsud is a group of specialized venture capital funds including Financière Spin-off Luxembourgeoise dedicated to encourage industrial and commercial implementation of results from research by Universities or other companies. The "Financière Spin-Off Luxembourgeoise" was created as a joint venture by the Walloon region and Investsud.